Aprazer Healthcare Launched Indenza
Launch Date: 13-07-2020
Aprazer Healthcare Launched INDENZA ( ENZULATAMIDE ) which is a medication indicated for the treatment of castration-resistant prostate cancer (CRPC) and metastatic castration-sensitive prostate cancer (mCSPC) .